Demethoxycurcumin suppresses migration and invasion of MDA-MB-231 human breast cancer cell line

European Journal of Pharmacology

Volumn 627, Issue 1-3, 2010, Pages 8-15

  Yodkeeree, Supachai ^a,c   Ampasavate, Chadarat ^b   Sung, Bokyung ^c   Aggarwal, Bharat B ^c   Limtrakul, Pornngarm ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer invasion; Curcuminoids; Demethoxycurcumin; Matrix metalloproteinases (MMPs); Nuclear factor kappa B (NF B); Urokinase plasminogen activator (uPA)

Indexed keywords

ANTINEOPLASTIC AGENT; CHEMOKINE RECEPTOR CXCR4; DEMETHOXYCURCUMIN; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MATRIX METALLOPROTEINASE 14; PLASMINOGEN ACTIVATOR INHIBITOR; UROKINASE; UROKINASE RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN TARGETING; RECEPTOR UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CURCUMIN; DNA; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NF-KAPPA B; RECEPTORS, CXCR4;

EID: 73449138207     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.09.052     Document Type: Article

References (48)

1. Balduyck M., Zerimech F., Gouyer V., Lemaire R., Hemon B., Grard G., Thiebaut C., Lemaire V., Dacquembronne E., Duhem T., Lebrun A., Dejonghe M.J., and Huet G. Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin. Exp. Metastasis 18 (2000) 171-178
2. Bertrand J.R., Pottier M., Vekris A., Opolon P., Maksimenko A., and Malvy C. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem. Biophys. Res. Commun. 296 (2002) 1000-1004
3. Bogenrieder T., and Herlyn M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22 (2003) 6524-6536
4. Cavallaro U., and Christofori G. Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim. Biophys. Acta 1552 (2001) 39-45
5. Chambers A.F., Groom A.C., and MacDonald I.C. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2 (2002) 563-572
6. Chang H.J., Kim M.H., Baek M.K., Park J.S., Chung I.J., Shin B.A., Ahn B.W., and Jung Y.D. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells. Anticancer Res. 27 (2007) 3411-3417
7. Connelly L., Robinson-Benion C., Chont M., Saint-Jean L., Li H., Polosukhin V.V., Blackwell T.S., and Yull F.E. A transgenic model reveals important roles for the NF-kappa B alternative pathway (p100/p52) in mammary development and links to tumorigenesis. J. Biol. Chem. 282 (2007) 10028-10035
8. Dano K., Romer J., Nielsen B.S., Bjorn S., Pyke C., Rygaard J., and Lund L.R. Cancer invasion and tissue remodeling-cooperation of protease systems and cell types. APMIS 107 (1999) 120-127
9. Delassus G.S., Cho H., Park J., and Eliceiri G.L. New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells. J. Cell Physiol. 217 (2008) 739-744
10. Duffy M.J. Urokinase plasminogen activator and its inhibitor, PAI-1, as prognostic markers in breast cancer: from pilot to level 1 evidence studies. Clin. Chem. 48 (2002) 1194-1197
11. Han G., Bi R., Le Q., Zhao L.L., Dong Y., and Lin Q.H. Study on effect of demethoxycurcumin in Curcuma long on stability of curcumin. Zhong Yao Cai 31 (2008) 592-594
12. Han G., Cui J.J., Bi R., Zhao L.L., and Zhang W.G. Study on stability of curcumine, demethoxycurcumin and bisdemethoxycurcumin. Zhongguo Zhong Yao Za Zhi 33 (2008) 2611-2614
13. Helbig G., Christopherson II K.W., Bhat-Nakshatri P., Kumar S., Kishimoto H., Miller K.D., Broxmeyer H.E., and Nakshatri H. NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J. Biol. Chem. 278 (2003) 21631-21638
14. Hong J.H., Ahn K.S., Bae E., Jeon S.S., and Choi H.Y. The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo. Prostate Cancer Prostatic Dis. 9 (2006) 147-152
15. Huang M.T., Ma W., Lu Y.P., Chang R.L., Fisher C., Manchand P.S., Newmark H.L., and Conney A.H. Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Carcinogenesis 16 (1995) 2493-2497
16. Jiang J., Slivova V., Valachovicova T., Harvey K., and Sliva D. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int. J. Oncol. 24 (2004) 1093-1099
17. Kim J.H., Shim J.S., Lee S.K., Kim K.W., Rha S.Y., Chung H.C., and Kwon H.J. Microarray-based analysis of anti-angiogenic activity of demethoxycurcumin on human umbilical vein endothelial cells: crucial involvement of the down-regulation of matrix metalloproteinase. Jpn. J. Cancer Res. 93 (2002) 1378-1385
18. Kiuchi F., Goto Y., Sugimoto N., Akao N., Kondo K., and Tsuda Y. Nematocidal activity of turmeric: synergistic action of curcuminoids. Chem. Pharm. Bull. (Tokyo) 41 (1993) 1640-1643
19. Kunnumakkara A.B., Anand P., and Aggarwal B.B. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 269 (2008) 199-225
20. Lerebours F., Vacher S., Andrieu C., Espie M., Marty M., Lidereau R., and Bieche I. NF-kappa B genes have a major role in inflammatory breast cancer. BMC Cancer 8 (2008) 41
21. Limtrakul P., Anuchapreeda S., and Buddhasukh D. Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. BMC Cancer 4 (2004) 13
22. Liotta L.A., Tryggvason K., Garbisa S., Hart I., Foltz C.M., and Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284 (1980) 67-68
23. Look M.P., van Putten W.L., Duffy M.J., Harbeck N., Christensen I.J., Thomssen C., Kates R., Spyratos F., Ferno M., Eppenberger-Castori S., Sweep C.G., Ulm K., Peyrat J.P., Martin P.M., Magdelenat H., Brunner N., Duggan C., Lisboa B.W., Bendahl P.O., Quillien V., Daver A., Ricolleau G., Meijer-van Gelder M.E., Manders P., Fiets W.E., Blankenstein M.A., Broet P., Romain S., Daxenbichler G., Windbichler G., Cufer T., Borstnar S., Kueng W., Beex L.V., Klijn J.G., O'Higgins N., Eppenberger U., Janicke F., Schmitt M., and Foekens J.A. Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J. Natl. Cancer Inst. 94 (2002) 116-128
24. Luo B.H., Carman C.V., and Springer T.A. Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25 (2007) 619-647
25. Manna S.K., Zhang H.J., Yan T., Oberley L.W., and Aggarwal B.B. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J. Biol. Chem. 273 (1998) 13245-13254
26. Maruo Y., Gochi A., Kaihara A., Shimamura H., Yamada T., Tanaka N., and Orita K. ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer. Int. J. Cancer 100 (2002) 486-490
27. Meijer-van Gelder M.E., Look M.P., Peters H.A., Schmitt M., Brunner N., Harbeck N., Klijn J.G., and Foekens J.A. Urokinase-type plasminogen activator system in breast cancer: association with tamoxifen therapy in recurrent disease. Cancer Res. 64 (2004) 4563-4568
28. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
29. Mylona E., Alexandrou P., Mpakali A., Giannopoulou I., Liapis G., Markaki S., Keramopoulos A., and Nakopoulou L. Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma. Eur. J. Surg. Oncol. 33 (2007) 294-300
30. Nakshatri H., Bhat-Nakshatri P., Martin D.A., Goulet Jr. R.J., and Sledge Jr. G.W. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth. Mol. Cell Biol. 17 (1997) 3629-3639
31. Pandey M.K., Sung B., Kunnumakkara A.B., Sethi G., Chaturvedi M.M., and Aggarwal B.B. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res. 68 (2008) 5370-5379
32. Pignatelli M., and Stamp G. Integrins in tumour development and spread. Cancer Surv. 24 (1995) 113-127
33. Rhode J., Fogoros S., Zick S., Wahl H., Griffith K.A., Huang J., and Liu J.R. Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells. BMC Complement Altern. Med. 7 (2007) 44
34. Rosette C., Roth R.B., Oeth P., Braun A., Kammerer S., Ekblom J., and Denissenko M.F. Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis 26 (2005) 943-950
35. Schmid B.C., Rudas M., Rezniczek G.A., Leodolter S., and Zeillinger R. CXCR4 is expressed in ductal carcinoma in situ of the breast and in atypical ductal hyperplasia. Breast Cancer Res. Treat. 84 (2004) 247-250
36. Sharma R.A., Euden S.A., Platton S.L., Cooke D.N., Shafayat A., Hewitt H.R., Marczylo T.H., Morgan B., Hemingway D., Plummer S.M., Pirmohamed M., Gescher A.J., and Steward W.P. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin. Cancer Res. 10 (2004) 6847-6854
37. Sharma C., Kaur J., Shishodia S., Aggarwal B.B., and Ralhan R. Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells. Toxicology 228 (2006) 1-15
38. Simon A., Allais D.P., Duroux J.L., Basly J.P., Durand-Fontanier S., and Delage C. Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure-activity relationships. Cancer Lett. 129 (1998) 111-116
39. Sliva D., Rizzo M.T., and English D. Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator. J. Biol. Chem. 277 (2002) 3150-3157
40. Sung B., Pandey M.K., Ahn K.S., Yi T., Chaturvedi M.M., Liu M., and Aggarwal B.B. Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis. Blood 111 (2008) 4880-4891
41. Suzuki M., Nakamura T., Iyoki S., Fujiwara A., Watanabe Y., Mohri K., Isobe K., Ono K., and Yano S. Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities. Biol. Pharm. Bull. 28 (2005) 1438-1443
42. Tang C.H., and Wei Y. The urokinase receptor and integrins in cancer progression. Cell. Mol. Life Sci. 65 (2008) 1916-1932
43. Wang Y.J., Pan M.H., Cheng A.L., Lin L.I., Ho Y.S., Hsieh C.Y., and Lin J.K. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 15 (1997) 1867-1876
44. Yasuda M., Tanaka Y., Tamura M., Fujii K., Sugaya M., So T., Takenoyama M., and Yasumoto K. Stimulation of beta1 integrin down-regulates ICAM-1 expression and ICAM-1-dependent adhesion of lung cancer cells through focal adhesion kinase. Cancer Res. 61 (2001) 2022-2030
45. Yodkeeree S., Garbisa S., and Limtrakul P. Tetrahydrocurcumin inhibits HT1080 cell migration and invasion via downregulation of MMPs and uPA. Acta Pharmacol. Sin. 29 (2008) 853-860
46. Yodkeeree S., Chaiwangyen W., Garbisa S., and Limtrakul P. Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA. J. Nutr. Biochem. 20 (2009) 87-95
47. Zhang J.S., Guan J., Yang F.Q., Liu H.G., Cheng X.J., and Li S.P. Qualitative and quantitative analysis of four species of Curcuma rhizomes using twice development thin layer chromatography. J. Pharm. Biomed. Anal. 48 (2008) 1024-1028
48. Zhang L.J., Wu C.F., Meng X.L., Yuan D., Cai X.D., Wang Q.L., and Yang J.Y. Comparison of inhibitory potency of three different curcuminoid pigments on nitric oxide and tumor necrosis factor production of rat primary microglia induced by lipopolysaccharide. Neurosci. Lett. 447 (2008) 48-53